Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Kehl, Haitham Elmarakeby, M. Nishino, E. Allen, E. Lepisto, M. Hassett, B. Johnson, D. Schrag (2019)
Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports.JAMA oncology
A. Esteva, Alexandre Robicquet, Bharath Ramsundar, Volodymyr Kuleshov, M. DePristo, Katherine Chou, Claire Cui, Greg Corrado, S. Thrun, J. Dean (2019)
A guide to deep learning in healthcareNature Medicine, 25
Deep Natural Language Processing to Ascertain Oncologic Outcomes From Radiology Reports at Scale Original Investigation Research Cooperative Oncology Groups. Clin Cancer Res. 38. Stead WW. Clinical implications and challenges a multi-center study. J Am Med Inform Assoc. 2018; 2012;18(1):256-262. doi:10.1158/1078-0432.CCR-11- of artificial intelligence and deep learning. JAMA. 25(9):1197-1201. doi:10.1093/jamia/ocy088 1633 2018;320(11):1107-1108. doi:10.1001/jama.2018.11029 42. Li X, Fireman BH, Curtis JR, et al. 35. Nasukawa T, Yi J. Sentiment analysis. In: 39. Pan SJ, Yang Q. A survey on transfer learning. Privacy-protecting analytical methods using only Proceedings of the International Conference on IEEE Trans Knowl Data Eng. 2010;22:1345-1359. aggregate-level information to conduct Knowledge Capture—K-CAP ’03. New York, doi:10.1109/TKDE.2009.191 multivariable-adjusted analysis in distributed data New York: ACM Press; 2003:70. networks. Am J Epidemiol. 2019;188(4):709-723. 40. Dayhoff JE, DeLeo JM. Artificial neural doi:10.1093/aje/kwy265 36. Mullard A. Learning from exceptional drug networks: opening the black box. Cancer. 2001;91 responders. Nat Rev Drug Discov. 2014;13(6):401- (8)(suppl):1615-1635. doi:10.1002/1097-0142 402. doi:10.1038/nrd4338 (20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L 37. Hinton G. Deep learning—a technology with the 41. Ratwani RM, Savage E, Will A, et al. A usability potential to transform health care. JAMA. 2018;320 and safety analysis of electronic health records: (11):1101-1102. doi:10.1001/jama.2018.11100 Invited Commentary Andrew Daniel Trister, MD, PhD Approaches to artificial
JAMA Oncology – American Medical Association
Published: Oct 25, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.